OncoPharm
John Bossaer
Add to My Podcasts
Episodes
About
Reviews
Promote
PARAMOUNT - Maintenance Pemetrexed
11 minutes
Posted Oct 3, 2025 at 4:25 pm.
0:00
11:09
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Our Landmarks of OncoPharm series returns to discuss PARAMOUNT, a landmark study that helped solidify the role of maintenance pemetrexed in NSCLC.
Previous
SC Pembro, Biotin, 5-yr POLARIX data
Next
Maintenance Therapy in Small Cell Lung Cancer
← See all 441 episodes of OncoPharm